Top and Current
Source: (remove) : David Lebovitz
RSSJSONXMLCSV
Top and Current
Source: (remove) : David Lebovitz
RSSJSONXMLCSV
Fri, August 2, 2024
Tue, June 25, 2024
Thu, April 25, 2024
Fri, February 16, 2024
Tue, October 10, 2023
Fri, August 4, 2023
Fri, February 24, 2023
Tue, February 1, 2022
Fri, October 29, 2021
Wed, August 4, 2021
Fri, July 30, 2021
Fri, July 16, 2021
Fri, April 30, 2021
Thu, February 18, 2021
Fri, February 12, 2021
Wed, November 25, 2020
Fri, November 13, 2020
Fri, November 6, 2020
Fri, October 30, 2020
Tue, October 13, 2020
Mon, August 31, 2020
Fri, August 7, 2020
Wed, July 15, 2020
Thu, May 21, 2020
Thu, May 7, 2020
Thu, April 2, 2020
Wed, February 26, 2020
Fri, February 7, 2020
Fri, January 17, 2020
Tue, December 17, 2019
Thu, November 21, 2019
Wed, November 20, 2019
Fri, October 11, 2019
Wed, August 7, 2019
Tue, March 5, 2019
Fri, September 28, 2018
Mon, August 13, 2018
Fri, August 3, 2018
Mon, May 7, 2018
Fri, February 9, 2018
Thu, November 9, 2017
Thu, September 21, 2017
Thu, August 10, 2017
Mon, July 10, 2017
Fri, October 7, 2016

David Lebovitz Maintained (ALNY) at Strong Buy with Increased Target to $342 on, Aug 2nd, 2024


Published on 2024-10-28 13:05:17 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Citigroup, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $291 to $342 on, Aug 2nd, 2024.

David has made no other calls on ALNY in the last 4 months.



There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $220 on, Monday, July 22nd, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $255 on, Friday, July 12th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Hold with Increased Target to $248 on, Wednesday, July 3rd, 2024


These are the ratings of the 7 analyists that currently disagree with David


  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $288 on, Friday, June 28th, 2024
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $295 on, Thursday, June 27th, 2024
  • Ritu Baral of "TD Cowen" Maintained at Strong Buy with Increased Target to $282 on, Tuesday, June 25th, 2024
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $260 on, Tuesday, June 25th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Monday, June 24th, 2024
  • Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Monday, June 24th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024